Skip to content
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
Itfy.in

At Itfy, we are dedicated to revolutionizing the way you receive news. Our mission is to provide timely, accurate, and personalized news updates using cutting-edge AI technology. Stay informed, stay ahead with us.

Itfy.in

At Itfy, we are dedicated to revolutionizing the way you receive news. Our mission is to provide timely, accurate, and personalized news updates using cutting-edge AI technology. Stay informed, stay ahead with us.

  • Home
  • News Updates
    • Latest News
    • Entertainment News
    • Northeast News
  • Technology
    • Digital Transformation
    • Artificial Intelligence
    • Machine Learning
    • Generative AI
    • Cybersecurity
  • Education & Growth
    • Education
    • Lifelong Learning
    • Parenting
    • Career Growth
  • Startup & Entrepreneurship
    • Remote Work
    • Startups
    • Digital Marketing
    • Social Media
    • Entrepreneurship
    • Lean Thinking
    • Personal Finance
  • Climate Justice
    • Climate Tech
  • Health & Wellness
    • Mental Health
  • Tourism
  • Home
  • News Updates
    • Latest News
    • Entertainment News
    • Northeast News
  • Technology
    • Digital Transformation
    • Artificial Intelligence
    • Machine Learning
    • Generative AI
    • Cybersecurity
  • Education & Growth
    • Education
    • Lifelong Learning
    • Parenting
    • Career Growth
  • Startup & Entrepreneurship
    • Remote Work
    • Startups
    • Digital Marketing
    • Social Media
    • Entrepreneurship
    • Lean Thinking
    • Personal Finance
  • Climate Justice
    • Climate Tech
  • Health & Wellness
    • Mental Health
  • Tourism
Close

Search

  • https://www.facebook.com/
  • https://twitter.com/
  • https://t.me/
  • https://www.instagram.com/
  • https://youtube.com/
Subscribe
Home/Latest News/Optimize Cancer Treatment Timing: Circadian Oncology Insights
Optimize Cancer Treatment Timing: Circadian Oncology Insights
Latest News

Optimize Cancer Treatment Timing: Circadian Oncology Insights

By adminitfy
August 13, 2026 2 Min Read

Researchers are increasingly linking the body’s circadian clock to cancer biology and treatment response, and they say timing medicines to a patient’s internal rhythm-chronotherapy-could lower toxicity and, in some cases, improve outcomes. The circadian system, driven by a central clock in the brain and peripheral clocks in tissues, controls DNA repair, cell division, hormone release, metabolism and immune function. Disrupting these rhythms-through shift work, nighttime light exposure, or sleep disturbance-has been epidemiologically associated with higher rates of some cancers and with worse symptoms, fatigue and quality of life in people with cancer.

At the molecular level, clock genes such as CLOCK and BMAL1 regulate PERIOD and CRYPTOCHROME proteins and interact with cancer pathways including c-Myc, Wnt/β‑catenin and Akt/mTOR. Depending on tumor type and context, clock proteins can either suppress or promote tumor growth; for example, BMAL1 influences p53 activity and the unfolded protein response, which affects cancer cell survival. In patients, altered rest-activity patterns and flattened diurnal cortisol have been studied as markers of circadian disruption and prognosis, though causation remains unproven.

Clinical studies of chronotherapy-timing chemotherapy, immunotherapy or radiotherapy to biological rhythms-have produced mixed but promising results. A systematic review of 18 randomized trials found that chronomodulated chemotherapy reduced toxicity in about 61% of studies but improved efficacy in only 17%. Specific timing patterns have been associated with fewer side effects: doxorubicin given in the morning (around 06:00) and cisplatin in the evening (roughly 16:00–20:00) showed lower complications in ovarian, recurrent endometrial and metastatic bladder cancer cohorts. Retrospective data in advanced melanoma suggest later-day immune‑checkpoint inhibitor infusions (for patients receiving ≥20% of doses after 4:30 pm) correlated with poorer survival, though this is observational and not proof of causation. As one review put it, “Anticancer therapy could take advantage of the mitotic rhythmicity of cells and apply the treatment depending on the time-of-day efficacy.”

Evidence for time-of-day effects in radiotherapy is inconsistent: some studies report differences in response or toxicity, while others-such as trials in high‑grade glioma-find no survival differences between morning and afternoon treatment. Overall, reducing treatment-related toxicity appears the more consistent benefit of chronoradiotherapy than clear gains in tumor control.

Implementing chronotherapy faces practical and biological hurdles. Hospital schedules, patient chronotypes, age, sex, comorbidities, drug regimens and tumor genetics all affect optimal timing. Tumors may maintain their own clocks and respond differently to systemic cues like glucocorticoids, feeding, and temperature.

New tools could help personalize timing. Wearables, smartwatches and research-grade actigraphy can track sleep and activity rhythms; biosensors and temperature or biochemical monitoring may estimate circadian phase. Computational models and programmable drug-delivery systems-possibly guided by AI-offer future promise but require prospective clinical validation. Meanwhile, circadian-supportive measures such as bright-light therapy, cognitive behavioral therapy for insomnia and exercise can improve sleep and fatigue, though evidence they extend survival is limited. Robust biomarkers and well-designed trials will be essential before chronotherapy becomes routine in cancer care.

Original Source: https://www.news-medical.net/health/Circadian-Oncology-Timing-Cancer-Treatment-and-Patient-Outcomes.aspx
Category:
Tags:
Publish Date: 2026-08-13 05:53:00

Author

adminitfy

Follow Me
Other Articles
STNM Hospital Readies Historic Kidney Transplant — Aug 15
Previous

STNM Hospital Readies Historic Kidney Transplant — Aug 15

Justice for UN Worker: US Court Orders Boeing to Pay $29M
Next

Justice for UN Worker: US Court Orders Boeing to Pay $29M

Search...

Recent Posts

  • পদত্যাগ অপৰাধ স্বীকাৰ নয়, নিৰ্দোষী যশৱন্ত ভাৰ্মাৰৰ লোকসভা সচিবালয়লৈ পত্ৰ
    পদত্যাগ অপৰাধ স্বীকাৰ নয়, নিৰ্দোষী যশৱন্ত ভাৰ্মাৰৰ লোকসভা সচিবালয়লৈ পত্ৰ
    by adminitfy
    November 20, 2026
  • Empowering Northeast India: CII’s CSR Connect Event Ignites Social Development
    by adminitfy
    July 3, 2024
  • Urgent Crisis: Northeast on High Alert as Death Toll Tragically Rises in Assam
    by adminitfy
    July 3, 2024
  • Triumphant Breakthrough: Security Forces Successfully Capture 4 Insurgents in Manipur Operation
    by adminitfy
    July 3, 2024

Welcome to the ultimate source for fresh perspectives! Explore curated content to enlighten, entertain and engage global readers.

  • Facebook
  • X
  • Instagram
  • LinkedIn

Latest Posts

  • পদত্যাগ অপৰাধ স্বীকাৰ নয়, নিৰ্দোষী যশৱন্ত ভাৰ্মাৰৰ লোকসভা সচিবালয়লৈ পত্ৰ
  • ক্ৰিমিয়া দলং আক্ৰমণত ক্ষুব্ধ পুটিন, ইউক্ৰেইনক প্ৰত্যুত্তৰৰ হুংকাৰ
  • Demographic Fuel: Immigration Policy and the Housing Demand Cycle
  • খলকনি! শ্বেয়াৰ বজাৰত এন্থ্ৰপিকৰ প্ৰৱেশ, ২ লাখ কোটি ডলাৰৰ ক্লাৱত
  • Cyclone Akvan Live: IMD Says Landfall Continues on Odisha-Andhra Coast
  • November 2026 (623)
  • October 2026 (646)
  • September 2026 (524)
  • August 2026 (1001)
  • July 2026 (986)
  • June 2026 (963)
  • May 2026 (922)
  • April 2026 (1525)
  • March 2026 (1522)
  • February 2026 (1252)
  • January 2026 (968)
  • December 2025 (942)
  • November 2025 (853)
  • October 2025 (869)
  • September 2025 (733)
  • August 2025 (810)
  • July 2025 (720)
  • June 2025 (1244)
  • May 2025 (2201)
  • April 2025 (1481)
  • March 2025 (2020)
  • February 2025 (1159)
  • January 2025 (1440)
  • December 2024 (1499)
  • November 2024 (1771)
  • October 2024 (1815)
  • September 2024 (1750)
  • August 2024 (1458)
  • July 2024 (1268)

Contact

Email

info@itfy.in

Location

INDIA

Copyright 2026 — Itfy.in. All rights reserved.